Page 8 - லாச்சேன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from லாச்சேன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In லாச்சேன் Today - Breaking & Trending Today
Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq in previously untreated patients with severe haemophilia A in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. Simoctocog Alfa (Nuwiq ) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1722623). The NuProtect study (NCT01712438; EudraCT 2012-002554-23) was a prospective, multinational, open-label, non-controlled phase III study initiated in March 2013 to assess the immunogenicity, efficacy and safety of Nuwiq ....
Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies European Journal of Haematology The publication, sponsored by Octapharma, marks the first pan-European consensus guidance on the use of IgRT in patients with hypogammaglobulinaemia secondary to haematological malignancies and aims to support harmonisation of clinical practice across Europe. Octapharma has a longstanding commitment to improving the management of patients with secondary immunodeficiencies (SID) and in 2020 launched PRO-SID, a phase III clinical trial investigating primary infection prophylaxis with intravenous immunoglobulin (IVIg) in patients with chronic lymphocytic leukaemia (CLL). These efforts address the need for both robust clinical data and unified guidance on managing infection risk in patients with SID. ....
Octapharma Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq® in Previously Untreated Patients With Severe Haemophilia A Thursday, February 18, 2021 4:01PM IST (10:31AM GMT)
LACHEN, Switzerland:
Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq ® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. “Simoctocog Alfa (Nuwiq ®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study” https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1722623).
The NuProtect study (NCT01712438; EudraCT 2012-002554-23) was a prospective, multinational, open-label, non-controlled phase III study initiated in March 2013 to assess ....
Octapharma: Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq in Previously Untreated Patients With Severe Haemophilia A in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. Simoctocog Alfa (Nuwiq ) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1722623). The NuProtect study (NCT01712438; EudraCT 2012-002554-23) was a prospective, multinational, open-label, non-controlled phase III study initiated in March 2013 to assess the immunogenicity, efficacy and safety of Nuwiq . The study recruited patients of any age and ethnicity at 38 sites in 17 countries and followed patients for 100 exposure days or up to 5 years. With enrolment of 110 patients, the NuProtect study was the largest clinical study to inv ....
The US branch office offers the whole range of SunBrush® mobil´s solar panel cleaners, which can be mounted quickly and easily on carrier vehicles, such as tractors or wheel loaders and guarantee efficient and gentle cleaning either dry or wet. Henderson, Nevada, January 14, 2021. The world market leader for PV cleaning systems from Germany, SunBrush® mobil, is breaking new ground with the opening of its branch office SunBrush USA in the city of Henderson, Nevada. There, the joint venture of SunBrush® mobil and its importer for the UK and Irish market Halse Solar Ltd will sell and maintain the PV cleaning systems of the German company and deliver spare parts to PV power plant operators, O&M companies and site owners across the US. We will fill a major gap with our products. Up to now, there has been no similar solar panel cleaning device in the US, says Franz Ehleuter, Managing Director of SunBrush® mobil. ....